9 | $AUMN 22% v4,7M c2.33 f8,573M Hod2.44 | znewcar1 | 10/23/2023 10:52:47 PM |
8 | $AUMN 49% v3,0M c1.90 f8,573M Hod1.94 ML.6 | znewcar1 | 10/20/2023 4:10:04 PM |
7 | $AUMN 47% c3,9M c1.36 f8,573M Hod1.55 ml.6 | znewcar1 | 10/18/2023 4:19:38 PM |
6 | AUMN 12% v1,544,603 c.44 162,8M04,612 | znewcar1 | 01/19/2022 5:50:28 PM |
5 | AUMN Stock year to date has changed -14.81% | Jake13 | 04/29/2015 3:45:57 PM |
4 | AUMN 0.46 Golden Minerals Co. Stock Charts $AUMN | chartguy89 | 04/29/2015 3:42:12 PM |
3 | AUMN 0.67 Golden Minerals Co. Stock Charts $AUMN | chartguy89 | 11/17/2014 11:14:07 PM |
2 | AUMN Year to date has changed +42.55% percent. | Jake13 | 11/17/2014 11:07:47 PM |
1 | Golden Minerals Company (AUMN) Keep a close eye | riddock57 | 02/28/2014 5:10:46 AM |
Recent Articles
- Elon Musk Defends Tesla's CEO Compensation Amid Criticism
- Chery Group Strengthens Commitment to Global Education Initiatives
- Revolutionizing Workplace Comfort with Elevated Seating Innovation
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study